John Hering was inspired to co-found Biograph following the early thyroid cancer diagnosis of his Vy Capital partner, Alexander Tamas. The company has been operating quietly since 2020 and is currently seeking a founding AI engineer to develop an AI-powered assistant. Biograph is part of a growing trend in longevity-focused startups, alongside companies like Function Health and Retro Biosciences. The article was reported by Charles Rollet, a senior reporter at TechCrunch, known for his investigative work leading to U.S. government sanctions against tech firms.
Key takeaways:
- Biograph, co-founded by Dr. Peter Attia and John Hering, is a new preventive health startup focused on longevity and diagnostics.
- The company offers memberships costing $7,500 to $15,000 annually, providing extensive health evaluations to optimize lifespan.
- Biograph is backed by notable investors including Vy Capital, Human Capital, and angel investors like Balaji Srinivasan.
- The startup is part of a growing trend in longevity-focused companies, with plans to expand globally and incorporate AI technology.